Page last updated: 2024-08-17

spironolactone and chlormadinone acetate

spironolactone has been researched along with chlormadinone acetate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Potts, GO; Schane, HP1
Schindler, AE1
Cantabrana, B; Garcia Valencia, V; Gutierrez, M; Hidalgo, A; Sanchez, M1
Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M1
Begin, DJ; Labrie, F; Luthy, IA1
Zaun, H1
de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS1

Reviews

1 review(s) available for spironolactone and chlormadinone acetate

ArticleYear
[Anti-androgen therapy in the female].
    Geburtshilfe und Frauenheilkunde, 1990, Volume: 50, Issue:10

    Topics: Androgen Antagonists; Androgens; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Humans; Spironolactone

1990

Trials

1 trial(s) available for spironolactone and chlormadinone acetate

ArticleYear
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
    Contraception, 2012, Volume: 86, Issue:3

    Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation

2012

Other Studies

6 other study(ies) available for spironolactone and chlormadinone acetate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Oral progestational activity of spironolactone.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:3

    Topics: Animals; Castration; Chlormadinone Acetate; Endometrium; Estradiol; Female; Macaca mulatta; Menstruation; Progestins; Rabbits; Spironolactone

1978
Effects of steroidal and non-steroidal antiandrogens on the left atrium of the rat in vitro.
    General pharmacology, 1991, Volume: 22, Issue:6

    Topics: Androgen Antagonists; Animals; Calcium; Chlormadinone Acetate; Cimetidine; Cyproterone; Electric Stimulation; Female; Flutamide; Heart; Heart Atria; In Vitro Techniques; Male; Medroxyprogesterone; Myocardial Contraction; Rats; Rats, Inbred Strains; Spironolactone; Steroids; Stimulation, Chemical

1991
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
    Journal of steroid biochemistry, 1987, Volume: 28, Issue:4

    Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone

1987
Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture.
    Journal of steroid biochemistry, 1988, Volume: 31, Issue:5

    Topics: Androgens; Animals; Cell Division; Chlormadinone Acetate; Dihydrotestosterone; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Mice; Progestins; Spironolactone; Tumor Cells, Cultured

1988
[Indications and limits of anti-androgen therapy].
    Zeitschrift fur Hautkrankheiten, 1984, Aug-15, Volume: 59, Issue:16

    Topics: Acne Vulgaris; Alopecia; Androgen Antagonists; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Therapy, Combination; Female; Hirsutism; Humans; Male; Skin Diseases; Spironolactone

1984